News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- Opinion: STAT+: Create a U.S. Institute of Health Technology Assessment to preserve innovation and control costs
- STAT+: 5 names to know: the key players steering Amazon’s sprawling push into health care
- Opinion: Using a collective ‘virtuous cycle’ to break the pandemic
- The ‘other’ epidemic: Amid Covid-19, addiction experts fear Biden could back-burner the overdose crisis
- The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
- Pfizer the latest pharma to befriend Iktos for its AI drug discovery platform
- FogPharma comes through the clearing with a meaty $107M raise for 'undruggable' targets
- ReForm taps ex-Genzyme exec to lead subcut delivery strategy
- ScPharmaceuticals plots refiling of twice-rejected on-body drug delivery product
- STAT+: A surprise FDA advisory panel imperils Fibrogen’s experimental anemia pill
- STAT+: A nascent state effort would tax drug makers for not providing clinical evidence for price hikes
- STAT+: New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines
- J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public
- FDA clears novel neck collar to help protect student athletes' brains from sports-related injuries
- W.R. Grace lays out $570M for Albemarle unit to bolster pharma portfolio, API manufacturing